Piper Sandler Downgrades Apyx Medical Corp. (APYX) to Neutral

Piper Sandler analyst Matt O'Brien downgraded Apyx Medical Corp. (NASDAQ: APYX) from Overweight to Neutral with a price target of $2.00.

For an analyst ratings summary and ratings history on Apyx Medical Corp. click here. For more ratings news on Apyx Medical Corp. click here.

Shares of Apyx Medical Corp. closed at $2.07 yesterday.

You May Also Be Interested In

• William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
• Nomura/Instinet Downgrades Brother Industries Ltd (6448:JP) to Neutral
• Deutsche Bank Downgrades Workday (WDAY) to Hold